Samargandi Osama A, Al-Taha Mona, Moran Kit, Al Youha Sarah, Bezuhly Michael
Halifax, Nova Scotia, Canada.
From the Division of Plastic and Reconstructive Surgery and the Faculty of Medicine, Dalhousie University.
Plast Reconstr Surg. 2018 Jan;141(1):152e-162e. doi: 10.1097/PRS.0000000000003960.
The p value is one of the most used descriptors in statistical analysis; however, when reported in isolation, it does not convey the effect size of a treatment. The reporting of confidence intervals is an essential adjunct to determine the clinical value of treatment, as it permits an assessment of the effect size. The authors assessed the reporting of confidence intervals in clinical trials within the plastic surgery literature.
The seven highest impact plastic surgery journals were screened using MEDLINE for clinical trials in the years 2006, 2009, 2012, and 2015. Studies were randomized based on a predetermined sample size, and various characteristics (e.g., Jadad quality score, reporting of statistical significance, journal impact factor, and participation of an individual with formal research training) were documented.
Two independent reviewers analyzed 135 articles. There was substantial interrater agreement (kappa = 0.78). Although 86.7 percent of studies reported a p value, only 25.2 percent reported confidence intervals. Of all journals assessed, Plastic and Reconstructive Surgery most frequently reported confidence intervals. The quality of the studies had a median Jadad score of 2 of 5. Bivariate analysis revealed that higher Jadad score and involvement of an individual with formal research training were associated with reporting of confidence intervals. Multivariate analysis revealed similar findings, whereas journal impact factor, year of publication, and statistical significance were not correlated with confidence interval reporting.
Confidence intervals are underreported in the plastic surgery literature. To improve reporting quality of clinical trials, results should always include the confidence intervals to avoid misinterpretation of the effect size of a statistically significant result.
P值是统计分析中最常用的描述指标之一;然而,单独报告时,它并不能传达治疗的效应大小。置信区间的报告是确定治疗临床价值的重要辅助手段,因为它有助于评估效应大小。作者评估了整形外科学术文献中临床试验置信区间的报告情况。
利用医学在线数据库(MEDLINE)对2006年、2009年、2012年和2015年发表在七本影响最大的整形外科学术期刊上的临床试验进行筛选。根据预先确定的样本量对研究进行随机分组,并记录各种特征(如雅达德质量评分、统计学显著性报告、期刊影响因子以及接受正规研究培训人员的参与情况)。
两名独立评审员分析了135篇文章。评分者间的一致性很高(kappa = 0.78)。虽然86.7%的研究报告了P值,但只有25.2%的研究报告了置信区间。在所有评估的期刊中,《整形与重建外科》最常报告置信区间。这些研究的质量,雅达德评分中位数为2(满分5分)。双变量分析显示,较高的雅达德评分以及有正规研究培训人员的参与与置信区间的报告相关。多变量分析也得出了类似的结果,而期刊影响因子、发表年份和统计学显著性与置信区间报告无关。
整形外科学术文献中置信区间的报告不足。为提高临床试验的报告质量,结果应始终包括置信区间,以避免对具有统计学显著性结果的效应大小产生误解。